UPMC Expands Reach in Italy with Outpatient Diagnostic Center
PITTSBURGH, June 6, 2014 – Adding to its successful transplant and cancer treatment facilities in Italy, UPMC announced today that it is expanding its Italian operations to include outpatient diagnostic services for liver and digestive disorders in the Region of Tuscany.
UPMC is managing and operating the new center, the UPMC Institute for Health, at the Terme di Chianciano Spa in Chianciano Terme. Located near Siena, between Florence and Rome, the facility will build on the traditional attraction of the spa’s thermal water therapies and is expected to attract patients from throughout Italy and beyond when it opens on June 9, 2014.
The new center will offer diagnostic screenings, imaging and procedures for liver and digestive disorders, cardiovascular diseases, diabetes and other illnesses. Patients also will be educated about personal risk factors, healthy lifestyle and diet. Those who need more advanced care may be referred to local hospitals or to other UPMC facilities in Italy, namely the ISMETT transplant hospital in Palermo and the UPMC San Pietro Cancer Center in Rome.
“Building on our long reputation for clinical excellence in Italy, we are proud to expand our high-quality services into a new region of the country,” said Charles Bogosta, president of UPMC’s International and Commercial Services Division. “This popular destination for patients will now have the only facility in the area that can offer a complete digestive check-up in a place that already draws thousands of people every year to its healing waters.”
UPMC is partnering with Terme di Chianciano, a company that operates and manages historical thermal premises in the region, as well as with the municipality and the local health care authority. UPMC is leasing and renovating the spa’s existing medical center.
“With UPMC’s clinical, scientific and management know-how and the well-established treatments of Chianciano Spa, this partnership will deliver a higher level of services to patients in one convenient location,” said Bruno Gridelli, M.D., medical and scientific director of UPMC’s International and Commercial Services Division and chief executive officer of ISMETT.
UPMC’s international footprint already includes operations or services in Italy, Ireland, India, Canada, China, Singapore, Japan and Kazakhstan. Through its international growth and commercialization efforts with industry partners, UPMC is diversifying its revenue base, fueling economic development in its communities, and strengthening its ability to recruit and retain the best and brightest clinicians who are working together to improve health care outcomes globally.